Geode Capital Management’s Celularity CELU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$254K Buy
191,076
+30,886
+19% +$39.1K ﹤0.01% 3841
2025
Q4
$178K Buy
160,190
+20,876
+15% +$37.4K ﹤0.01% 3947
2025
Q3
$288K Buy
139,314
+4,489
+3% +$12.6K ﹤0.01% 3811
2025
Q2
$264K Sell
134,825
-1,216
-0.9% -$2.21K ﹤0.01% 3780
2025
Q1
$235K Buy
136,041
+4,531
+3% +$8.58K ﹤0.01% 3787
2024
Q4
$274K Sell
131,510
-5,964
-4% -$14.2K ﹤0.01% 3799
2024
Q3
$408K Sell
137,474
-4,081
-3% -$12K ﹤0.01% 3670
2024
Q2
$443K Buy
141,555
+6,912
+5% +$24K ﹤0.01% 3605
2024
Q1
$704K Buy
134,643
+36,832
+38% +$151K ﹤0.01% 3488
2023
Q4
$242K Hold
97,811
﹤0.01% 3867
2023
Q3
$217K Buy
97,811
+10,098
+12% +$36.3K ﹤0.01% 3948
2023
Q2
$467K Sell
87,713
-28,200
-24% -$181K ﹤0.01% 3674
2023
Q1
$718K Buy
115,913
+668
+0.6% +$5.38K ﹤0.01% 3507
2022
Q4
$1.49M Buy
115,245
+1,139
+1% +$21K ﹤0.01% 3179
2022
Q3
$2.63M Buy
114,106
+95,128
+501% +$2.89M ﹤0.01% 2987
2022
Q2
$645K Buy
18,978
+11,927
+169% +$969K ﹤0.01% 3623
2022
Q1
$614K Hold
7,051
﹤0.01% 3842
2021
Q4
$361K Buy
7,051
+396
+6% +$25.3K ﹤0.01% 4209
2021
Q3
$471K Buy
+6,655
New +$537K ﹤0.01% 4057
2020
Q4
Sell
-1,000
Closed -$105K 4272
2020
Q3
$105K Buy
+1,000
New +$104K ﹤0.01% 3890

Other funds holding CELU

Geode Capital Management's CELU Position: Q1 2026 in Review

Geode Capital Management increased its Celularity (CELU) stake by 19% in Q1 2026, buying an estimated $39.1K and bringing the position to 191,076 shares worth $254K. The position accounts for ﹤0.01% of the portfolio, ranked #3841.

Geode Capital Management first reported a position in CELU in Q3 2020 and has held it in 20 quarters since. The position peaked at $2.63M in Q3 2022. 38 funds tracked by Wall St. Rank hold CELU as of Q1 2026.

  • Geode Capital Management held 191,076 shares of Celularity worth $254K as of Q1 2026.
  • Geode Capital Management bought 30,886 Celularity shares in Q1 2026, an estimated $39.1K.
  • Celularity made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #3841 holding.
  • Geode Capital Management first reported a position in Celularity in Q3 2020 and has held it in 20 quarters since.
  • Geode Capital Management's Celularity position peaked at $2.63M in Q3 2022.
  • 38 funds tracked by Wall St. Rank held Celularity as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.